ID   L612
AC   CVCL_3733
DR   CLO; CLO_0007208
DR   ABCD; ABCD_AF198
DR   Wikidata; Q54901823
RX   Patent=US5419904;
RX   PubMed=7916649;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10724.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI:84118; Ganglioside GM3.
CC   Monoclonal antibody target: ChEBI; CHEBI:27499; Ganglioside GM4.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a breast carcinoma.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000027.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
RX   Patent=US5419904;
RA   Irie R.F.;
RT   "Human B-lymphoblastoid cell line secreting anti-ganglioside antibody.";
RL   Patent number US5419904, 30-May-1995.
//
RX   PubMed=7916649;
RA   Hoon D.S.B., Wang Y., Sze L.L., Kanda H., Watanabe T., Morrison S.L.,
RA   Morton D.L., Irie R.F.;
RT   "Molecular cloning of a human monoclonal antibody reactive to
RT   ganglioside GM3 antigen on human cancers.";
RL   Cancer Res. 53:5244-5250(1993).
//